文献速递外周动脉疾病

腹股沟下旁路术后手术部位感染预测因素:VQI数据分析

Predictors of surgical site infection following infrainguinal bypass surgery: An analysis of the Vascular Quality Initiative data.
PubMed 文献 · J Vasc Surg · 2025-10-22

本研究基于VQI数据库2010至2024年59221例因外周动脉疾病行腹股沟下旁路术患者,回顾性分析术后手术部位感染(SSI)的预测因素。1857例(3.1%)发生SSI,多变量分析确认肥胖、非美国保险、静息痛、组织缺损、未治疗慢阻肺、重度心衰、未治疗糖尿病、终末期肾病、术中输血及手术时间延长为危险因素,而药物控制糖尿病、术前抗生素、人工血管及单独氯己定或碘消毒为保护因素。

要点

  • 腹股沟下旁路术后SSI发生率为3.1%,肥胖等级越高风险越大。
  • 术中输血、手术时间≥150分钟及未控制的糖尿病、心衰、慢阻肺增加SSI风险。
  • 术前抗生素、药物控制糖尿病、人工血管及单独氯己定或碘消毒与较低SSI风险相关。

核心结论

  • 肥胖、未治疗慢阻肺、重度心衰、未治疗糖尿病、终末期肾病、静息痛或组织缺损、术中输血及手术时间延长增加腹股沟下旁路术后SSI风险。
  • 术前抗生素、药物控制糖尿病、人工血管及单独氯己定或碘消毒与较低SSI风险相关。

研究设计与样本

  • 回顾性分析VQI数据库2010至2024年因外周动脉疾病行腹股沟下旁路术的59221例患者。
  • 排除同侧大截肢、腹股沟上旁路、急性肢体缺血或动脉瘤性疾病患者,采用多变量logistic回归识别SSI危险因素。

主要发现

  • 59221例中1857例(3.1%)发生SSI。
  • 非美国保险(OR 2.84,95%CI 1.43-5.65,P=.003)和肥胖(BMI 25-29.9:OR 1.43,95%CI 1.09-1.88,P=.01;BMI 30-40:OR 1.64,95%CI 1.21-2.21,P<.001;BMI≥40:OR 2.22,95%CI 1.57-3.13,P<.001)与SSI风险增加相关。
  • 静息痛(OR 1.23,95%CI 1.01-1.49,P=.04)和组织缺损(OR 1.67,95%CI 1.38-2.03,P<.001)与SSI风险增加相关。
  • 未治疗慢阻肺(OR 1.21,95%CI 1.01-1.44,P=.04)、重度心衰(OR 1.89,95%CI 1.13-3.14,P=.01)、未治疗糖尿病(OR 1.32,95%CI 1.02-1.70,P=.03)及终末期肾病(OR 1.83,95%CI 1.01-3.33,P=.046)与SSI显著相关。
  • 术中输血(OR 2.28,95%CI 2.00-2.59,P<.001)、手术时间≥150分钟(OR 1.51,95%CI 1.20-1.89,P<.001)及≥300分钟(OR 1.95,95%CI 1.50-2.54,P<.001)增加SSI风险。

关键数值与推荐

  • 药物控制糖尿病(OR 0.75,95%CI 0.58-0.97,P<.03)、术前抗生素(OR 0.74,95%CI 0.64-0.85,P<.001)、人工血管(OR 0.85,95%CI 0.74-0.99,P=.03)为保护因素。
  • 皮肤准备单独使用氯己定(OR 0.49,95%CI 0.34-0.69,P<.001)或单独碘(OR 0.52,95%CI 0.33-0.84,P=.007)优于氯己定-碘联合。

临床怎么用

  • 对肥胖、未控制糖尿病、心衰、慢阻肺、终末期肾病及组织缺损患者加强术前优化以降低SSI风险。
  • 重视术前抗生素规范使用、尽量缩短手术时间及减少术中输血。
  • 皮肤准备可优先考虑单独氯己定或单独碘消毒。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Surgical site infection (SSI) is a common complication after infrainguinal bypass (IIB) in patients with peripheral artery disease, leading to significant morbidity, including prolonged hospital stays, increased readmission rates, graft failure, and mortality. Despite advances in aseptic techniques, SSI continues to impact patient outcomes, driven by a complex interplay of patient-specific and procedural factors. This study aims to identify predictors of postoperative SSI in patients undergoing IIB providing insights into potentially modifiable risk factors. METHODS: We performed a retrospective analysis of all patients undergoing IIB for peripheral artery disease in the Vascular Quality Initiative database from 2010 to 2024. Patients with concomitant ipsilateral major amputation, suprainguinal bypass, acute limb ischemia, or aneurysmal disease were excluded. Multivariable logistic regression was used to identify risk factors associated with postoperative SSI. RESULTS: Of 59,221 patients undergoing IIB, 1857 (3.1%) developed SSI. Patients with SSI were more likely to be female, obese, and have chronic kidney disease or congestive heart failure (CHF). Urgent procedures, longer operative times, intraoperative blood transfusions, autogenous grafts, and below-knee bypasses were also more common in the SSI group. Multivariable analysis identified several significant predictors of SSI. Among patient factors, non-U.S. insurance (odds ratio [OR]: 2.84; 95% confidence interval [CI]: 1.43-5.65; P = .003) and obesity (body mass index [BMI] 25-29.9: OR: 1.43, 95% CI: 1.09-1.88, P = .01; BMI 30-40: OR: 1.64, 95% CI: 1.21-2.21, P < .001; BMI ≥40: OR: 2.22, 95% CI: 1.57-3.13, P < .001) were associated with an increased risk of SSI. Rest pain (OR: 1.23; 95% CI: 1.01-1.49; P = .04) and tissue loss (OR: 1.67; 95% CI: 1.38-2.03; P<.001) were also associated with increased risks of SSI. Comorbidities, including untreated chronic obstructive pulmonary disease (OR: 1.21; 95% CI: 1.01-1.44; P = .04), severe CHF (OR: 1.89; 95% CI: 1.13-3.14; P = .01), untreated diabetes mellitus (DM) (OR: 1.32; 95% CI: 1.02-1.70; P = .03), and end-stage renal disease (OR: 1.83; 95% CI: 1.01-3.33; P = .046), were significantly associated with SSI. Perioperative factors such as intraoperative blood transfusion (OR: 2.28; 95% CI: 2.00-2.59; P < .001), prolonged operative time ≥150 minutes (OR: 1.51; 95% CI: 1.20-1.89; P < .001), and ≥300 minutes (OR: 1.95; 95% CI: 1.50-2.54; P < .001) increased the risk of SSI. Protective factors included medication-controlled DM (OR: 0.75; 95% CI: 0.58-0.97; P < .03), preoperative antibiotics (OR: 0.74; 95% CI: 0.64-0.85; P < .001), prosthetic grafts (OR: 0.85; 95% CI: 0.74-0.99; P = .03), and using chlorhexidine (CHG) or iodine alone vs CHG-iodine combined for skin preparation (CHG: OR: 0.49, 95% CI: 0.34-0.69, P < .001; iodine: OR: 0.52, 95% CI: 0.33-0.84, P = .007). CONCLUSIONS: This study confirms several risk factors for SSI including increased SSI risk with higher BMI, chronic obstructive pulmonary disease, CHF, untreated DM, rest pain or tissue loss presentation, intraoperative blood transfusion, and prolonged operative time. Protective factors, including preoperative antibiotic use, and medication-controlled DM and hypertension underscore the importance of optimizing perioperative care to reduce SSI risk. These findings highlight opportunities for targeted interventions and personalized risk stratification to reduce SSI and improve patient outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rahgozar S, Hamouda M, Farber A, et al. Predictors of surgical site infection following infrainguinal bypass surgery: An analysis of the Vascular Quality Initiative data. J Vasc Surg. 2025. PMID: 41135721. doi:10.1016/j.jvs.2025.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。